Compare Sana Biotechnology Inc (SANA) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Tyson Foods, Inc. — how do they compare? Sana Biotechnology Inc trades at $2.79 (market cap $836.71M), while Tyson Foods, Inc. trades at $53.43 (market cap $18.41B). The key difference: Tyson Foods, Inc. is far larger — about 22× Sana Biotechnology Inc's market cap, and Tyson Foods, Inc. pays a 3.9% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Sana Biotechnology Inc for 23 Days and Tyson Foods, Inc. for 76 Days on average.
| SANA | TSN | |
|---|---|---|
Market Cap | $836.71M | $18.41B |
Volume | 4,507,444 | 3,757,599 |
Sector | Health | Consumer Staples |
52-Week High | $5.92 | $68.75 |
52-Week Low | $2.68 | $50.47 |
Typical Hold Time | 23 Days | 76 Days |
Enterprise Value | $749.96M | $25.68B |
Dividend Yield | — | 3.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $2.79, up 2.57% today, but faces significant fundamental challenges with negative revenue, substantial losses, and bearish technical indicators. The company reported a net loss of $244.17 million in 2025 with no revenue, while technical analysis shows a bearish trend with moving averages and ADX indicators signaling selling pressure. Recent news highlights multiple investor conference presentations and ongoing legal scrutiny regarding fiduciary duties.
Despite strong analyst support (82% buy ratings), SANA's lack of revenue generation and negative profitability metrics present substantial investment risk. The company's cash flow remains negative, requiring continued financing. Near-term catalysts include upcoming Q3 earnings and clinical developments, but investors should weigh the high-risk profile against potential long-term biotechnology breakthroughs.
Tyson Foods (TSN) trades at $52.34, up 1.24% on the day, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported revenue of $54.44 billion in 2025, with a net income margin of 1.03%, while recent earnings show two beats and one miss. Analysts maintain a consensus buy rating with a $65.40 price target, but news highlights challenges in the beef segment and ongoing securities investigations.
The outlook for TSN is cautiously optimistic, supported by analyst confidence and dividend stability, but risks include margin pressure from beef losses, legal scrutiny, and volatile cash flows. The stock's valuation at a P/E of 32.31 appears elevated relative to modest profitability, requiring careful monitoring of execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
